All market verdicts

DXCM DOWN market verdict | Ezbrisk

Published: 1785941606535

Anomaly score: -2.8054537257298984

Confidence: 0.85

Market summary

Insulet guidance cut

Ezbrisk assessment

DexCom is sliding violently after competitor Insulet lowered its annual revenue forecast, which has sparked broader concerns about slowing growth across the continuous glucose monitoring industry.

Sources: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGuU3VTHOd2KP3z5AtLSYo_bJRf5dp2qvRunbY3hSoaNdCXwbUUbeFtnKhOlMtx7KprqkUvTmXyHwtQCAHYNj8FI5tP4qfHaE-z6MzSwwKvwKIXPX6BYAsrw5OU8tJ9hZFALQuKs0qLlxhJoo-KOwBXq7EpqW0oBv6FXTbBOb1MURnJU8Av

Verdict ID: 4a67a015-5ec3-4ff9-acd5-2ab4701f2ebd